Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
Covington
Cerilliant
Daiichi Sankyo
US Department of Justice
Julphar
Mallinckrodt
McKesson

Generated: June 22, 2018

DrugPatentWatch Database Preview

IONAMIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Ionamin patents expire, and when can generic versions of Ionamin launch?

Ionamin is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in IONAMIN is phentermine resin complex. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the phentermine resin complex profile page.
Summary for IONAMIN
Drug patent expirations by year for IONAMIN
Synonyms for IONAMIN
.alpha.,.alpha.-Dimethylphenethylamine
.alpha..alpha.Dimethylphenethylamine
(alpha,alpha)-Dimethylphenethylamine
1-benzyl-iso-propyl amine
1-METHYL-3-BENZENEPROPANAMINE
1,1-DIMETHYL-2-PHENYL-ETHYLAMINE
1,1-Dimethyl-2-phenylethylamine
1197-21-3 (hydrochloride)
122-09-8
12674-13-4
2-Amino-2-methyl-1-phenylpropane
2-Methyl-1-phenyl-2-propanamine
2-methyl-1-phenylpropan-2-amine
2-Phenyl-tert-butylamine
9008-94-0
A,A-DIMETHYL-BENZENEETHANAMINE
AB02355
AC1L1IX2
Adipex P (TN)
Adipex-P
AKOS004123261
alpha-Benzylisopropylamine
alpha,alpha-Dimethyl-beta-phenylethylamine
alpha,alpha-Dimethylbenzeneethanamine
alpha,alpha-Dimethylphenethylamine
alpha,alpha-Dimethylphenethylamine solution
alpha.,.alpha.-dimethyl-Benzeneethanamine
AmbkkkkK744
Anoxine-AM (TN)
BDBM50246598
Benzeneethanamine, .alpha.,.alpha.-dimethyl-
BENZENEETHANAMINE, A,A-DIMETHYL-
Benzeneethanamine, alpha,alpha-dimethyl-
BRN 0970319
C045TQL4WP
C07438
CHEBI:8080
CHEMBL1574
CTK8G3912
D05458
D0U0RZ
DB00191
DEA No. 1640
DHHVAGZRUROJKS-UHFFFAOYSA-N
DTXSID9023461
Duromine
Duromine (TN)
EC 204-522-1
EINECS 204-522-1
Ethanamine, 1,1-dimethyl-2-phenyl-
Fastin
Fastin (TN)
Fentermina
Fentermina [INN-Spanish]
FT-0716831
GTPL7269
HMS2093B16
HSDB 3158
InChI=1/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H
Inoamin
Ionamin (TN)
Ionamine
Linyl
Lipopill
Lonamin
LS-103327
Mirapront
Mirapront (TN)
Normephentermine
NSC-759163
NSC759163
Obenix
Obenix (TN)
Obephen (TN)
Obermine
Obermine (TN)
Obestin-30 (TN)
Oby-Trim (TN)
Omnibex
Ona Mast
OR001177
OR209421
Panbesy (TN)
Pharmakon1600-01505660
Phenethylamine, .alpha.,.alpha.-dimethyl-
Phenethylamine, alpha,alpha-dimethyl-
Phentercot
Phenterex (TN)
phentermine
Phentermine (TN)
Phentermine (USAN/INN)
Phentermine [USAN:INN:BAN]
Phentermine 0.1 mg/ml in Methanol
Phentermine 1.0 mg/ml in Methanol
PHENTERMINE BASE
Phentermine resin
Phentermine Resin 30
Phentermine resin complex
Phentermine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Phenterminum
Phenterminum [INN-Latin]
Phentremene (TN)
Phentride
Phentrol
Phentrol (TN)
Phentrol 2
Phentrol 3
Phentrol 4
Phentromin (TN)
Phenyl-tert-butylamine
Phenyl-tertiary-butylamine
Pro-Fast
Pro-Fast SA (TN)
RCRA waste no. P046
RCRA waste number P046
Redusa (TN)
SBI-0206817.P001
SCHEMBL26615
Sinpet (TN)
SR-05000001805
SR-05000001805-2
Supremin (TN)
Teramine (TN)
Trenker (TN)
Umine (TN)
UNII-C045TQL4WP
Weltmine (TN)
Wilpo
X-2149
Zantryl
Zantryl (TN)
ZINC8403947

US Patents and Regulatory Information for IONAMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc IONAMIN phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 011613-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc IONAMIN phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 011613-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
US Department of Justice
Johnson and Johnson
Moodys
Boehringer Ingelheim
Federal Trade Commission
Argus Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.